Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Operating Profit Rate for 28 FJPWA-Affiliated OTC Drug Wholesalers Up 0.41 Points
March 26, 2007
- Nippon Chemiphar to Enter Chinese Market, Expand Generic Business
March 26, 2007
- Spread of Use of Steroids Reduces Asthma Deaths: GSK Seminar
March 26, 2007
- SymBio Licenses AB-1001 from Abeille
March 26, 2007
- Multiple Drug-Resistant P. Aeruginosa Detected in 85.8% of Core Hospitals
March 26, 2007
- Wholesalers Should Ally with Dispensing Pharmacies: Mr Kimura
March 26, 2007
- Number of Local Gov't Hospitals Drops below 1,000: MIC White Paper
March 26, 2007
- BUSINESS NEWS IN BRIEF
March 26, 2007
- Generics to Be Listed for 6 Major Products with Sales of Over \10 Bil.
March 26, 2007
- Nippon Shinyaku Aims at 3% Growth in Mid, Long Term
March 19, 2007
- New Q&A Issued on Strengths of Generics
March 19, 2007
- NBI's Training System Boosts MR Productivity
March 19, 2007
- Ain Pharamaciez to Sell Generics Outside Group from April
March 19, 2007
- BUSINESS NEWS IN BRIEF
March 19, 2007
- MEDICAL DEVICE NEWS IN BRIEF
March 19, 2007
- 7 APIs Including Celecoxib to Be Included in NHI Price List
March 19, 2007
- Efficacy of Narcotic Analgesics Predicted by Gene Polymorphisms
March 19, 2007
- Gov't-Private Sector Dialogueto Be Held on Distribution
March 19, 2007
- Consider Licensing, Not Independent Marketing, in Advanced Countries: Mr Seko
March 19, 2007
- Warning against Exacerbation of Hepatitis Added to Package Insert of Rituximab
March 19, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…